Business Description
Medmix AG
ISIN : CH1129677105
Description
Medmix AG delivers technologies in high-precision delivery devices and fluid mixing for applications. It is into two business areas Healthcare and Consumer & Industrial. The Healthcare business area is divided into the Dental, Drug Delivery and Surgery segments. The Consumer & Industrial business area operates through the Industry and Beauty segments. The majority of revenue is from Consumer & Industrial segment. In the Industry segment, dispensers, cartridges, and mixers are used in the construction, transportation (automotive, railways and aerospace), electronics assembly, infrastructure and DIY industries. Geographically, it operates in Europe the Middle East and Africa, the Americas and Asia-Pacific.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.48 | |||||
| Equity-to-Asset | 0.5 | |||||
| Debt-to-Equity | 0.65 | |||||
| Debt-to-EBITDA | 4.71 | |||||
| Interest Coverage | 3.53 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.68 | |||||
| Beneish M-Score | -1.8 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.4 | |||||
| 3-Year EBITDA Growth Rate | -4.9 | |||||
| 3-Year EPS without NRI Growth Rate | -22.9 | |||||
| 3-Year FCF Growth Rate | -44.5 | |||||
| 3-Year Book Growth Rate | 19.9 | |||||
| Future 3-5Y Total Revenue Growth Rate | 8.35 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 26.74 | |||||
| 9-Day RSI | 31.25 | |||||
| 14-Day RSI | 36.09 | |||||
| 6-1 Month Momentum % | 42.5 | |||||
| 12-1 Month Momentum % | 46.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.31 | |||||
| Quick Ratio | 1.65 | |||||
| Cash Ratio | 1.03 | |||||
| Days Inventory | 107.44 | |||||
| Days Sales Outstanding | 45.61 | |||||
| Days Payable | 60.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.14 | |||||
| Dividend Payout Ratio | 2.17 | |||||
| Forward Dividend Yield % | 2.14 | |||||
| 5-Year Yield-on-Cost % | 2.16 | |||||
| 3-Year Average Share Buyback Ratio | 0.3 | |||||
| Shareholder Yield % | -5.05 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 33.33 | |||||
| Operating Margin % | 5.73 | |||||
| Net Margin % | 2.04 | |||||
| ROE % | 1.93 | |||||
| ROA % | 0.95 | |||||
| ROIC % | 4.61 | |||||
| ROC (Joel Greenblatt) % | 5.34 | |||||
| ROCE % | 1.83 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 101.52 | |||||
| Forward PE Ratio | 12.82 | |||||
| PE Ratio without NRI | 101.52 | |||||
| PS Ratio | 2.03 | |||||
| PB Ratio | 1.96 | |||||
| Price-to-Tangible-Book | 7.64 | |||||
| Price-to-Operating-Cash-Flow | 26.15 | |||||
| EV-to-EBIT | 72.64 | |||||
| EV-to-Forward-EBIT | 15.15 | |||||
| EV-to-EBITDA | 16.43 | |||||
| EV-to-Forward-EBITDA | 8.72 | |||||
| EV-to-Revenue | 2.33 | |||||
| EV-to-Forward-Revenue | 1.96 | |||||
| EV-to-FCF | -120.25 | |||||
| Price-to-Graham-Number | 5.82 | |||||
| Earnings Yield (Greenblatt) % | 1.38 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medmix AG Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil CHF) | 474.6 | ||
| EPS (TTM) (CHF) | 0.23 | ||
| Beta | 0 | ||
| Volatility % | 32.87 | ||
| 14-Day RSI | 36.09 | ||
| 14-Day ATR (CHF) | 0.815504 | ||
| 20-Day SMA (CHF) | 24.8075 | ||
| 12-1 Month Momentum % | 46.19 | ||
| 52-Week Range (CHF) | 15.55 - 26.75 | ||
| Shares Outstanding (Mil) | 40.88 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medmix AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medmix AG Stock Events
| Event | Date | Price(CHF) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medmix AG Frequently Asked Questions
What is Medmix AG(XSWX:MEDX)'s stock price today?
The current price of XSWX:MEDX is CHF23.00. The 52 week high of XSWX:MEDX is CHF26.75 and 52 week low is CHF15.55.
When is next earnings date of Medmix AG(XSWX:MEDX)?
The next earnings date of Medmix AG(XSWX:MEDX) is .
Does Medmix AG(XSWX:MEDX) pay dividends? If so, how much?
The Dividend Yield %  of Medmix AG(XSWX:MEDX) is 2.14% (As of Today), Highest Dividend Payout Ratio of Medmix AG(XSWX:MEDX) was 2.17. The lowest was 1.79. And the median was 1.79. The  Forward Dividend Yield % of Medmix AG(XSWX:MEDX) is 2.14%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers